Glucocorticoid activity, inactivity and the osteoblast

被引:53
作者
Cooper, MS [1 ]
Hewison, M [1 ]
Stewart, PM [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1677/joe.0.1630159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids clearly regulate several crucial determinants of osteoblast differentiation, proliferation and function. These effects are complex and at times opposing, depending upon dose and stage of osteoblast differentiation. In addition to improving our understanding of glucocorticoid action, we are now increasingly aware of important factors that regulate glucocorticoid 'inactivity' within osteoblasts. In keeping with other peripheral target tissues, the expression of 11β-HSD isozymes within human bone suggests that corticosteroid hormone action is modulated at a pre-receptor level. Further studies are required to define the regulation of 11β-HSD within human osteoblasts at varying stages of differentiation, but the manipulation of 11β-HSD within bone itself may, in the future, offer a novel therapeutic approach in modulating glucocorticoid 'activity' or 'inactivity' in bone.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 33 条
[1]   Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids [J].
Bamberger, CM ;
Schulte, HM ;
Chrousos, GP .
ENDOCRINE REVIEWS, 1996, 17 (03) :245-261
[2]   DETERMINATION OF THE CAPACITY FOR PROLIFERATION AND DIFFERENTIATION OF OSTEOPROGENITOR CELLS IN THE PRESENCE AND ABSENCE OF DEXAMETHASONE [J].
BELLOWS, CG ;
HEERSCHE, JNM ;
AUBIN, JE .
DEVELOPMENTAL BIOLOGY, 1990, 140 (01) :132-138
[3]   Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines [J].
Bland, R ;
Worker, CA ;
Noble, BS ;
Eyre, LJ ;
Bujalska, IJ ;
Sheppard, MC ;
Stewart, PM ;
Hewison, M .
JOURNAL OF ENDOCRINOLOGY, 1999, 161 (03) :455-464
[4]   Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro [J].
Boden, SD ;
McCuaig, K ;
Hair, G ;
Racine, M ;
Titus, L ;
Wozney, JM ;
Nanes, MS .
ENDOCRINOLOGY, 1996, 137 (08) :3401-3407
[5]   Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6 [J].
Boden, SD ;
Hair, G ;
Titus, L ;
Racine, M ;
McCuaig, K ;
Wozney, JM ;
Nanes, MS .
ENDOCRINOLOGY, 1997, 138 (07) :2820-2828
[6]   Production of collagenase by human osteoblasts and osteoclasts in vivo [J].
Bord, S ;
Horner, A ;
Hembry, RM ;
Reynolds, JJ ;
Compston, JE .
BONE, 1996, 19 (01) :35-40
[7]   Does central obesity reflect ''Cushing's disease of the omentum''? [J].
Bujalska, IJ ;
Kumar, S ;
Stewart, PM .
LANCET, 1997, 349 (9060) :1210-1213
[8]   Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis [J].
Canalis, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3441-3447
[9]   GLUCOCORTICOID REGULATION OF TRANSFORMING GROWTH FACTOR-BETA-1 ACTIVITY AND BINDING IN OSTEOBLAST-ENRICHED CULTURES FROM FETAL-RAT BONE [J].
CENTRELLA, M ;
MCCARTHY, TL ;
CANALIS, E .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4490-4496
[10]  
CHAMBERS TJ, 1985, J CELL SCI, V76, P155